107 related articles for article (PubMed ID: 22932461)
1. [Expression of cell cycle regulator ATM, Chk2 and p53 and their clinicopathological correlation in breast infiltrative ductal carcinoma].
Pei XJ; Yang QX; Liu SJ; Su M; Huang ZY; Han AJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):479-80. PubMed ID: 22932461
[No Abstract] [Full Text] [Related]
2. ATM protein synthesis patterns in sporadic breast cancer.
Kairouz R; Clarke RA; Marr PJ; Watters D; Lavin MF; Kearsley JH; Lee CS
Mol Pathol; 1999 Oct; 52(5):252-6. PubMed ID: 10748873
[TBL] [Abstract][Full Text] [Related]
3. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
Miyasaka Y; Nagai E; Yamaguchi H; Fujii K; Inoue T; Ohuchida K; Yamada T; Mizumoto K; Tanaka M; Tsuneyoshi M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4371-7. PubMed ID: 17671118
[TBL] [Abstract][Full Text] [Related]
4. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase.
Treilleux I; Chapot B; Goddard S; Pisani P; Angèle S; Hall J
Histopathology; 2007 Jul; 51(1):63-9. PubMed ID: 17593081
[TBL] [Abstract][Full Text] [Related]
5. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
[TBL] [Abstract][Full Text] [Related]
7. [What do we know about ATM protein expression in breast tissue?].
Angèle S; Tanière P; Hall J
Bull Cancer; 2001 Jul; 88(7):671-5. PubMed ID: 11495820
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase inhibitor coralyne photosensitizes DNA, leading to elicitation of Chk2-dependent S-phase checkpoint and p53-independent apoptosis in cancer cells.
Patro BS; Maity B; Chattopadhyay S
Antioxid Redox Signal; 2010 Apr; 12(8):945-60. PubMed ID: 19922265
[TBL] [Abstract][Full Text] [Related]
9. How to activate p53.
Caspari T
Curr Biol; 2000 Apr; 10(8):R315-7. PubMed ID: 10801407
[TBL] [Abstract][Full Text] [Related]
10. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
Wang HC; Chou WC; Shieh SY; Shen CY
Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
12. ATM and Chk2 kinase target the p53 cofactor Strap.
Adams CJ; Graham AL; Jansson M; Coutts AS; Edelmann M; Smith L; Kessler B; La Thangue NB
EMBO Rep; 2008 Dec; 9(12):1222-9. PubMed ID: 18833288
[TBL] [Abstract][Full Text] [Related]
13. The combined status of ATM and p53 link tumor development with therapeutic response.
Jiang H; Reinhardt HC; Bartkova J; Tommiska J; Blomqvist C; Nevanlinna H; Bartek J; Yaffe MB; Hemann MT
Genes Dev; 2009 Aug; 23(16):1895-909. PubMed ID: 19608766
[TBL] [Abstract][Full Text] [Related]
14. ATM activation is accompanied with earlier stages of prostate tumorigenesis.
Fan C; Quan R; Feng X; Gillis A; He L; Matsumoto ED; Salama S; Cutz JC; Kapoor A; Tang D
Biochim Biophys Acta; 2006 Oct; 1763(10):1090-7. PubMed ID: 16997395
[TBL] [Abstract][Full Text] [Related]
15. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases.
Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P
Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814
[TBL] [Abstract][Full Text] [Related]
16. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
Gurley KE; Kemp CJ
Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
[TBL] [Abstract][Full Text] [Related]
17. Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper Egypt.
Hussein MR; Ismael HH
Cancer Biol Ther; 2004 Oct; 3(10):983-8. PubMed ID: 15467428
[TBL] [Abstract][Full Text] [Related]
18. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients.
Salimi M; Mozdarani H; Majidzadeh K
Med Oncol; 2012 Sep; 29(3):1502-9. PubMed ID: 21850541
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
